Bioequivalence- FlexibilityExample

• Ritonavir SGC vs. Liquid

• Assessment

  • Outliers
  • Low reference formulation bioavailability
    • Review of previous studies
  • Supporting safety data from NDA: 700 mg bid

Previous slide

Next slide

Back to first slide

View graphic version